CompletedPhase 2NCT00457288
Efficacy and Safety of TF002 in Cutaneous Mastocytosis
Studying Cutaneous mastocytosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- JADO Technologies GmbH
- Principal Investigator
- Marcus Maurer, ProfCharite University, Berlin, Germany
- Intervention
- TF 002(drug)
- Enrollment
- 30 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2007 – 2007
Study locations (4)
- Klinik und Poliklinik für Dermatologie und Venerologie der Universität, Cologne, Köln, Germany
- Universitäts-Hautklinik, Mainz, Germany
- Klinik und Poliklinik für Dermatologie und Allergologie der LMU, München, Germany
- Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein der TU, München, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00457288 on ClinicalTrials.govOther trials for Cutaneous mastocytosis
Additional recruiting or active studies for the same condition.